Fry J
J R Coll Gen Pract. 1976 Sep;26(170):643-6.
An appreciation of the natural history of angina pectoris is important when deciding on the place of new and potentially dangerous forms of treatment. During 1950-1975, 268 patients with angina were diagnosed and followed up in my London general practice. The annual incidence, in adults over 40, was five per 1,000 and increased with age.During the period of follow-up, half the patients died, an annual mortality of 4.6 per cent. However, among the survivors one third ceased to suffer anginal symptoms spontaneously and without specific therapy. Of those who continued to suffer from angina, in 71 per cent the condition was graded as minor, in 27 per cent as moderate, and in only two per cent were the attacks severe and disabling. Usually the angina was primary (77 per cent) and it was secondary, after myocardial infarction, in 23 per cent.Of the 134 deaths, three quarters were from a cardiovascular cause. This group of angina patients had a 2:1 times greater observed, than expected, risk of dying (O/E ratio). The O/E mortality ratio fell progressively with age. It was highest in the 40-49 decade (4.0) and lowest in the over 80s, when the observed mortality rate was less than expected (0.9). The O/E mortality ratio was higher in men (2.3) than in women (1.7).From this survey I conclude that angina does not have a uniformly bad prognosis, and that with the advent of beta-adrenergic blockers, the proportion considered for angiocardiography and aorto-coronary bypass grafting should be less than five per cent of all patients with angina.
在决定新的、可能有风险的治疗方法的应用时,了解心绞痛的自然病史很重要。1950年至1975年期间,我在伦敦的普通诊所诊断并随访了268例心绞痛患者。40岁以上成年人的年发病率为千分之五,且随年龄增长而增加。在随访期间,一半的患者死亡,年死亡率为4.6%。然而,在幸存者中,三分之一的患者未经特殊治疗便自发停止了心绞痛症状。在那些继续患有心绞痛的患者中,71%的病情为轻度,27%为中度,只有2%的发作严重且致残。通常心绞痛是原发性的(77%),心肌梗死后继发性的占23%。在134例死亡病例中,四分之三是心血管原因导致的。这群心绞痛患者的观察到的死亡风险比预期高2倍(观察/预期比值)。观察/预期死亡率随年龄逐渐下降。在40至49岁年龄段最高(4.0),在80岁以上最低,此时观察到的死亡率低于预期(0.9)。观察/预期死亡率男性(2.3)高于女性(1.7)。从这项调查中我得出结论,心绞痛的预后并非一律很差,并且随着β肾上腺素能阻滞剂的出现,考虑进行心血管造影和主动脉冠状动脉搭桥术的患者比例应低于所有心绞痛患者的5%。